Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin (Q40964731)

25 September 2017

title

Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin (English)

1 reference

25 September 2017

M Hopf

1 reference

25 September 2017

W Göhring

1 reference

25 September 2017

E Kohfeldt

1 reference

25 September 2017

Y Yamada

1 reference

25 September 2017

R Timpl

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

25 September 2017

1 reference

25 September 2017

volume

259

1 reference

25 September 2017

1 reference

25 September 2017

page(s)

917-925

1 reference

Proteoglycans of basement membranes

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

An amino-terminal extension is required for the secretion of chick agrin and its binding to extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Perlecan and basement membrane-chondroitin sulfate proteoglycan (bamacan) are two basement membrane chondroitin/dermatan sulfate proteoglycans in the Engelbreth-Holm-Swarm tumor matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Electron microscopic structure of agrin and mapping of its binding site in laminin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Alternative splicing of agrin regulates its binding to heparin alpha-dystroglycan, and the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Expression and characterization of human perlecan domains I and II synthesized by baculovirus-infected insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Human basement membrane heparan sulfate proteoglycan core protein: a 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Structure and distribution of modules in extracellular proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Nidogen-2: a new basement membrane protein with diverse binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Binding of mouse and human fibulin-2 to extracellular matrix ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Binding of perlecan to transthyretin qin vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Recombinant domain III of perlecan promotes cell attachment through its RGDS sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Structural and cell-adhesive properties of three recombinant fragments derived from perlecan domain III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Structural characterization of recombinant domain II of the basement membrane proteoglycan perlecan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Structural Properties of Recombinant Domain III-3 of Perlecan Containing a Globular Domain Inserted into an Epidermal-Growth-Factor-Like Motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

The immunoglobulin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Binding properties and protease stability of recombinant human nidogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Characterization of proteolytic fragments of the laminin-nidogen complex and their activity in ligand-binding assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Properties of the extracellular calcium binding module of the proteoglycan testican

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Binding of nidogen and the laminin-nidogen complex to basement membrane collagen type IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

22 Antibodies to collagens and procollagens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Perlecan, the large low-density proteoglycan of basement membranes: structure and variant forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Crystal structure of three consecutive laminin-type epidermal growth factor-like (LE) modules of laminin gamma1 chain harboring the nidogen binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

Structural characterization of the complete human perlecan gene and its promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00127.X

10.1046/J.1432-1327.1999.00127.X

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference